Combination adjunctive nebulized furosemide and salbutamol versus single agent therapy in COPD patients: A randomized controlled trial
Author:
Funder
Kashan University of Medical Sciences, Kashan, Iran
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference52 articles.
1. Alternative projection of mortality and disability by cause 1990–2020: global burden of disease study;Murray;Lancet,1997
2. COPD.epidemiology, prevalence, morbidity and mortality, and disease heterogeneity;Mannino;Chest,2002
3. Trends in the leading causes of death in the United States, 1970–2002;Jemal;J. Am. Med. Assoc.,2005
4. The relationship between chronic obstructive pulmonary disease and frailty: a systematic review and meta-analysis of observational studies;Marengoni;Chest,2018
5. Effect of symptoms on physical performance in COPD;Lee,2018
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nebulised furosemide for the treatment of patients with obstructive lung disease: a systematic review protocol;BMJ Open;2023-11
2. Nebulized medications in the emergency department: A narrative review of nontraditional agents;American Journal of Health-System Pharmacy;2023-10-25
3. Drug combinations for inhalation: Current products and future development addressing disease control and patient compliance;International Journal of Pharmaceutics;2023-08
4. Unraveling the Impact of Salbutamol Polytherapy: Clinically Relevant Drug Interactions;Future Pharmacology;2023-03-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3